189 related articles for article (PubMed ID: 29730586)
1. Overlap between harm reduction and HIV service utilisation among PWID in India: Implications for HIV combination prevention.
Smith MK; Solomon SS; Cummings DAT; Srikrishnan AK; Kumar MS; Vasudevan CK; McFall AM; Lucas GM; Celentano DD; Mehta SH
Int J Drug Policy; 2018 Jul; 57():111-118. PubMed ID: 29730586
[TBL] [Abstract][Full Text] [Related]
2. Correlates of anti-hepatitis C positivity and use of harm reduction services among people who inject drugs in two cities in Croatia.
Handanagic S; Sevic S; Barbaric J; Dominkovic Z; Dakovic Rode O; Begovac J; Bozicevic I
Drug Alcohol Depend; 2017 Feb; 171():132-139. PubMed ID: 28088084
[TBL] [Abstract][Full Text] [Related]
3. Service utilization and cost of implementing a comprehensive HIV prevention and care program among people who inject drugs in Delhi, India.
Sebastian MP; Dasgupta A; Saraswati LR; Singh A; Sharma V; Madan I; Tun W; Pulerwitz J; Thior I; Sarna A
Harm Reduct J; 2017 Jun; 14(1):38. PubMed ID: 28615077
[TBL] [Abstract][Full Text] [Related]
4. Injection network drivers of HIV prevention service utilization among people who inject drugs: results of a community-based sociometric network cohort in New Delhi, India.
Prata Menezes NS; Mehta SH; Wesolowski A; Clipman SJ; Srikrishnan AK; Kumar MS; Zook KJC; Lucas GM; Latkin C; Solomon SS
J Int AIDS Soc; 2024 Apr; 27(4):e26241. PubMed ID: 38632848
[TBL] [Abstract][Full Text] [Related]
5. Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study.
Cepeda JA; Eritsyan K; Vickerman P; Lyubimova A; Shegay M; Odinokova V; Beletsky L; Borquez A; Hickman M; Beyrer C; Martin NK
Lancet HIV; 2018 Oct; 5(10):e578-e587. PubMed ID: 30033374
[TBL] [Abstract][Full Text] [Related]
6. Access to harm reduction programs among persons who inject drugs: findings from a respondent-driven sampling survey in Tehran, Iran.
Rahnama R; Mohraz M; Mirzazadeh A; Rutherford G; McFarland W; Akbari G; Malekinejad M
Int J Drug Policy; 2014 Jul; 25(4):717-23. PubMed ID: 24974367
[TBL] [Abstract][Full Text] [Related]
7. Modelling integrated antiretroviral treatment and harm reduction services on HIV and overdose among people who inject drugs in Tijuana, Mexico.
Cepeda JA; Bórquez A; Magana C; Vo A; Rafful C; Rangel G; Medina-Mora ME; Strathdee S; Martin NK
J Int AIDS Soc; 2020 Jun; 23 Suppl 1(Suppl 1):e25493. PubMed ID: 32562375
[TBL] [Abstract][Full Text] [Related]
8. Has resourcing of non-governmental harm-reduction organizations in Ukraine improved HIV prevention and treatment outcomes for people who inject drugs? Findings from multiple bio-behavioural surveys.
Trickey A; Semchuk N; Saliuk T; Sazonova Y; Varetska O; Walker JG; Lim AG; Stone J; Vickerman P
J Int AIDS Soc; 2020 Aug; 23(8):e25608. PubMed ID: 32851812
[TBL] [Abstract][Full Text] [Related]
9. Perceived acceptability of and willingness to use syringe vending machines: results of a cross-sectional survey of out-of-service people who inject drugs in Tbilisi, Georgia.
Otiashvili D; Kirtadze I; Vardanashvili I; Tabatadze M; Ober AJ
Harm Reduct J; 2019 Mar; 16(1):21. PubMed ID: 30898120
[TBL] [Abstract][Full Text] [Related]
10. Young people who inject drugs in India have high HIV incidence and behavioural risk: a cross-sectional study.
Ganapathi L; McFall AM; Srikrishnan AK; Kumar MS; Anand S; Lucas GM; Mehta SH; Harris SK; Solomon SS
J Int AIDS Soc; 2019 May; 22(5):e25287. PubMed ID: 31116005
[TBL] [Abstract][Full Text] [Related]
11. Attitudes towards people living with HIV and people who inject drugs: A mixed method study of stigmas within harm reduction programs in Kazakhstan.
Stringer KL; Mukherjee T; McCrimmon T; Terlikbayeva A; Primbetovac S; Darisheva M; Hunt T; Gilbert L; El-Bassel N
Int J Drug Policy; 2019 Jun; 68():27-36. PubMed ID: 30981165
[TBL] [Abstract][Full Text] [Related]
12. Perspectives of clients and providers on factors influencing opioid agonist treatment uptake among HIV-positive people who use drugs in Indonesia, Ukraine, and Vietnam: HPTN 074 study.
Kiriazova T; Go VF; Hershow RB; Hamilton EL; Sarasvita R; Bui Q; Lancaster KE; Dumchev K; Hoffman IF; Miller WC; Latkin CA
Harm Reduct J; 2020 Oct; 17(1):69. PubMed ID: 32998731
[TBL] [Abstract][Full Text] [Related]
13. Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries.
Petersen Z; Myers B; van Hout MC; Plüddemann A; Parry C
Harm Reduct J; 2013 Aug; 10():13. PubMed ID: 23957896
[TBL] [Abstract][Full Text] [Related]
14. Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada.
Lanièce Delaunay C; Maheu-Giroux M; Marathe G; Saeed S; Martel-Laferrière V; Cooper CL; Walmsley S; Cox J; Wong A; Klein MB;
Int J Drug Policy; 2022 May; 103():103627. PubMed ID: 35218989
[TBL] [Abstract][Full Text] [Related]
15. HIV care continuum among men who have sex with men and persons who inject drugs in India: barriers to successful engagement.
Mehta SH; Lucas GM; Solomon S; Srikrishnan AK; McFall AM; Dhingra N; Nandagopal P; Kumar MS; Celentano DD; Solomon SS
Clin Infect Dis; 2015 Dec; 61(11):1732-41. PubMed ID: 26251048
[TBL] [Abstract][Full Text] [Related]
16. Access to and acceptability of sexual and reproductive health, harm reduction and other essential health services among people who inject drugs in Durban, South Africa.
Milford C; Cavanagh T; Bosman S; Wilson M; Smit J; Zanoni B
Harm Reduct J; 2024 Jun; 21(1):123. PubMed ID: 38926755
[TBL] [Abstract][Full Text] [Related]
17. Impact of harm minimization interventions on reducing blood-borne infection transmission and some injecting behaviors among people who inject drugs: an overview and evidence gap mapping.
Tonin FS; Alves da Costa F; Fernandez-Llimos F
Addict Sci Clin Pract; 2024 Feb; 19(1):9. PubMed ID: 38310293
[TBL] [Abstract][Full Text] [Related]
18. Using a programmatic mapping approach to plan for HIV prevention and harm reduction interventions for people who inject drugs in three South African cities.
Scheibe A; Shelly S; Lambert A; Schneider A; Basson R; Medeiros N; Padayachee K; Savva H; Hausler H
Harm Reduct J; 2017 Jun; 14(1):35. PubMed ID: 28592246
[TBL] [Abstract][Full Text] [Related]
19. Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.
Dutta A; Wirtz AL; Baral S; Beyrer C; Cleghorn FR
Curr Opin HIV AIDS; 2012 Jul; 7(4):362-8. PubMed ID: 22647588
[TBL] [Abstract][Full Text] [Related]
20. Young and invisible: a qualitative study of service engagement by people who inject drugs in India.
Ganapathi L; Srikrishnan AK; Martinez C; Lucas GM; Mehta SH; Verma V; McFall AM; Mayer KH; Hassan A; Rajan S; O'Cleirigh C; Harris SK; Solomon SS
BMJ Open; 2021 Sep; 11(9):e047350. PubMed ID: 34548348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
